Efficacy Study of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers
Condition: Oral Mucositis Interventions: Drug: RRx-001 + eLOOP Device; Radiation: Intensity-modulated radiation therapy; Drug: Cisplatin for injection 100 mg/m2 Sponsor: EpicentRx, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials